Author:
Ramaswamy Megha,Allison Molly,Musser Brynne,Satterwhite Catherine,Armstrong Robert,Kelly Patricia J.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Public Health, Environmental and Occupational Health,Health Policy
Reference24 articles.
1. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial;Muñoz;Lancet,2009
2. The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years;Wheeler;J Infect Dis,2009
3. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP);Markowitz;MMWR Recomm Rep,2014
4. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years—United States, 2017;Walker;MMWR Morb Mortal Wkly Rep,2018
5. Prevalence of chronic medical conditions among jail and prison inmates in the USA compared with the general population;Binswanger;J Epidemiol Community Health,2009
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献